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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S233“Result window” shows the cartilage information with gray (or color)
intensity over the 3D bone shape. The developed program can display
and save color DICOMMRI as shown in Fig. 2, and provide the statistical
information (Mean, Min, Max of thickness and Volume) of the local VOI
of “Lateral Condyle” and “Medial Condyle” as shown in the ﬁgures.
Conclusions: This paper proposes fully automatic cartilage segmenta-
tion and measurement method without any training process. The
proposed method can visualize the whole cartilage distribution with
the 3D bone shape. The experimental results demonstrate that it can be
used for inspecting cartilage damage or loss directly. The developed
software is therefore applicable in clinical knee OA diagnosis systems.
Future studies include more tests with newMRI data for conﬁrming the
accuracy of the measurements.(Acknowledgment: This study was
supported by a grant of the Korean Health Technology R&D project,
Ministry for Health, Welfare & Family Affairs, and Republic of Korea.
(A091120))
Fig. 1. Cartilage segmentation and measuring software for diagnosis of knee OA
(gray).
Fig. 2. Cartilage segmentation and measuring software for diagnosis of knee OA
(color).
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LITHIUM CHLORIDE - A NOVEL TREATMENT FOR OSTEOARTHRITIS?
T. Minashima, Y. Zhang, Y. Lee, T. Kirsch. NYU Langone Med. Ctr., New
York, NY, USA
Purpose: Lithium chloride (LiCl) is currently being used for the treat-
ment of bipolar disorder because of its ability to interact with various
receptors and affect major signaling pathways. In addition, it has been
suggested that LiCl may inhibit matrix metalloprotease (MMP)expression in interleukin (IL)-1-treated articular chondrocytes. Based
on its ability to modulate signaling pathways, we hypothesized that LiCl
inhibits cartilage degradation during osteoarthritis (OA). Therefore, the
purpose of this study was to determine the effects and mechanism of
action of LiCl on cartilage degradation during OA.
Methods: The expression of catabolic genes and the activation of NF-kB
in mouse and human articular chondrocytes cultured in the absence or
presence of 10ng / ml IL-1, 50ng / ml IL-6, 10mM LiCl, and 10mM
glycogen synthase kinase 3 (GSK-3) inhibitor SB-216763 (SB) were
determined by real time PCR and luciferase reporter assays. Cell lysates
from chondrocytes treated with IL-1, IL-1 / LiCl, or IL-1 / SB were
analyzed for mitogen activated protein kinase (MAPK) and signal
transducer and activator of transcription 3 (STAT3) activities by
immunoblotting. Cartilage degradation in mouse femoral head explants
cultured in the absence or presence of IL-1, LiCl and SB was determined
by safranin O staining, and measuring the release of glycosaminoglycan
(GAG) and IL-6 into the culture media by ELISA. Cartilage degradation in
a post-traumatic OA mouse model using the transection of the medial
collateral ligament and partial medial meniscetomy (PMX) after treat-
ment with vehicle or LiCl (weekly intraarticular injections for 8 weeks)
was analyzed histologically by toluidine blue staining.
Results: Cartilage degradation was markedly reduced in LiCl-treated
mice 8 weeks after PMX surgery compared with vehicle-treated mice
despite the fact that Li+ as a potent inhibitor of GSK-3 stimulates Wnt/b-
catenin signaling, a well-known signaling pathway that stimulates
cartilage degradation in surgical-induced mouse OA models. To deter-
mine the mechanisms of how LiCl protects articular cartilage against
degradation, we determined the effects of LiCl and the GSK-3 inhibitor
(SB) on catabolic events in IL-1-treated mouse articular chondrocytes.
Treatment with LiCl, but not SB, resulted in decreased mRNA levels of
catabolic markers, including ADAMTS-5, COX-2, IL-6, iNOS, and MMP-13,
in articular chondrocytes treated with IL-1. LiCl markedly reduced the
proteoglycan loss and the release of IL-6 in IL-1-treated mouse articular
chondrocytes or femoral head explants, whereas SB further increased
proteoglycan loss and IL-6 release in IL-1-treated chondrocytes or
explants. LiCl treatment markedly reduced NF-kB and p38 MAPK
signaling activities in IL-1-treated chondrocytes. As a consequence of
reduced IL-6 expression in LiCl and IL-1-treated chondrocytes, LiCl
markedly reduced Jak/STAT3 signaling activity in IL-1-treated chon-
drocytes. LiCl directly reduced Jak/STAT3 signaling activity in IL-6-treated
articular chondrocytes.
Conclusion: LiCl protects articular cartilage against degradation during
OA via the inhibition of major signaling pathways involved in OA
pathology, including NF-kB, p38 MAPK and STAT3 signaling. Our ﬁnd-
ings suggest that LiCl as a modulator of the activities of major signaling
pathways involved in OA pathology may act as novel compound for the
treatment of OA. The advantage of LiCl as a potential novel compound
for the treatment of OA is that LiCl is already approved for the treatment
of patients with bipolar disorders.
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UTILIZATION OF HIGH THROUGHPUT MECHANICAL SCREENING FOR
THE EVALUATION OF MECHANICAL PROPERTIES AND COMPRESSIVE
INJURY MODELS
B. Mohanraj, C. Hou, M. Schmidt, R.L. Mauck, G.R. Dodge. Univ. of
Pennsylvania, Philadelphia, PA, USA
Purpose: Restoration of cartilage after damage remains a perplexing
clinical issue. High throughput (HT) assays enable rapid screening of
chemical libraries for the discovery of novel compounds relevant to
tissue development and healing. For musculoskeletal tissue engi-
neering applications, HT technologies should also enable measurement
of construct mechanical properties, as the success of these repair
therapies will likely depend on their mechanical functionality. Similarly,
given the mechanical origin of certain diseases, such as post-traumatic
osteoarthritis (PTOA), HT methods for mechanical perturbation of
numerous constructs might prove beneﬁcial for the identifying novel
factors that modulate disease progression. Here we demonstrate that
a novel HT mechanical screening (HTMS) device can enable measure-
ment of compressive mechanical properties of biomaterials and induce
reproducible injury in engineered cartilage in a HT manner.
Methods: HTMS Testing of Hydrogels: 15% polyacrylamide (PA) and 4%
agarose (Ag) gels (Ø:4mm,H:2.25mm; n¼24/material) were tested
using a step-compression protocol in the 48 well device. Gels were
compressed to 10% strain over 200s and held for 1000s per step, for
